 "Brooks Lab soars 20% on receiving manufacturing licence for Gujarat facility")
Brooks Laboratories is locked at upper circuit of 20% at Rs 122 on the National Stock Exchange (NSE) on the back of heavy volumes after the company said it has got manufacturing license for its new manufacturing facility at Vadodra in Gujarat.
“The company's new manufacturing facility at Vadodra, Gujarat has been granted with manufacturing licence from Commissioner of Food & Drugs Control Administration, Gandhinagar, for manufacture of pharmaceutical products,” Brooks Laboratories said in a regulatory filing.
The manufacturing licence is valid for the period of 5 years from August 16, 2016 to August 15, 2021, it added.
Till 02:20 pm, a combined 2.84 million shares change hands and there were pending buy orders for 149,376 shares on the BSE and NSE.
“The company's new manufacturing facility at Vadodra, Gujarat has been granted with manufacturing licence from Commissioner of Food & Drugs Control Administration, Gandhinagar, for manufacture of pharmaceutical products,” Brooks Laboratories said in a regulatory filing.
The manufacturing licence is valid for the period of 5 years from August 16, 2016 to August 15, 2021, it added.
Till 02:20 pm, a combined 2.84 million shares change hands and there were pending buy orders for 149,376 shares on the BSE and NSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%